Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Halliday

Showing results (241-250 of 435) with videos related to

Pageof 44
Sort By:
The Plant Journal : for Cell and Molecular Biology|September 6, 2000
SRL1: a new locus specific to the phyB-signaling pathway in ArabidopsisE Huq, Y Kang, K J Halliday, et al.
Cancer|May 1, 1975
Human thoracic duct cannulation: manipulation of tumor-specific blocking factors in a patient with malignant melanomaW H Isbister, F P Noonan, W J Halliday, et al.
Journal of Paediatrics and Child Health|June 1, 1995
Home-based management of children hospitalized with acute gastroenteritisE V O'Loughlin, E Notaras, C McCullough, et al.
Gut|May 1, 1993
Absorbed aluminium is found with two cytosolic protein fractions, other than ferritin, in the rat duodenumM Cochran, G Goddard, G Ramm, et al.
The Australian Journal of Experimental Biology and Medical Science|October 1, 1980
Augmentation of E-rosette formation by lymphocytes of cancer patients stimulated in vitro with tumor extractsA E Maluish, T A Koppi, J J Harper, et al.
Cancer Research|August 1, 1977
Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapyF P Noonan, W J Halliday, D R Wall, et al.
Journal of the National Cancer Institute|August 1, 1980
Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancerW J Halliday, T A Koppi, J M Khan, et al.
International Journal of Cancer|October 15, 1975
Leukocyte adherence inhibition and specific immunoreactivity in malignant melanomaW J Halliday, A E Maluish, J H Little, et al.
Postgraduate Medical Journal|January 1, 1985
Dose response studies with propofol ('Diprivan') in unpremedicated patientsJ S McCollum, J W Dundee, N J Halliday, et al.
The Medical Journal of Australia|September 2, 1991
Failure to demonstrate contrast nephrotoxicityC A Heller, J Knapp, J Halliday, et al.
Pageof 44

Showing results (241-250 of 435) with videos related to

Sort By:
Pageof 44
The Plant Journal : for Cell and Molecular Biology|September 6, 2000
SRL1: a new locus specific to the phyB-signaling pathway in ArabidopsisE Huq, Y Kang, K J Halliday, et al.
Cancer|May 1, 1975
Human thoracic duct cannulation: manipulation of tumor-specific blocking factors in a patient with malignant melanomaW H Isbister, F P Noonan, W J Halliday, et al.
Journal of Paediatrics and Child Health|June 1, 1995
Home-based management of children hospitalized with acute gastroenteritisE V O'Loughlin, E Notaras, C McCullough, et al.
Gut|May 1, 1993
Absorbed aluminium is found with two cytosolic protein fractions, other than ferritin, in the rat duodenumM Cochran, G Goddard, G Ramm, et al.
The Australian Journal of Experimental Biology and Medical Science|October 1, 1980
Augmentation of E-rosette formation by lymphocytes of cancer patients stimulated in vitro with tumor extractsA E Maluish, T A Koppi, J J Harper, et al.
Cancer Research|August 1, 1977
Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapyF P Noonan, W J Halliday, D R Wall, et al.
Journal of the National Cancer Institute|August 1, 1980
Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancerW J Halliday, T A Koppi, J M Khan, et al.
International Journal of Cancer|October 15, 1975
Leukocyte adherence inhibition and specific immunoreactivity in malignant melanomaW J Halliday, A E Maluish, J H Little, et al.
Postgraduate Medical Journal|January 1, 1985
Dose response studies with propofol ('Diprivan') in unpremedicated patientsJ S McCollum, J W Dundee, N J Halliday, et al.
The Medical Journal of Australia|September 2, 1991
Failure to demonstrate contrast nephrotoxicityC A Heller, J Knapp, J Halliday, et al.
Pageof 44